Sangamo Therapeutics Announces Presentations At Upcoming Investor Conferences

RICHMOND, Calif., March 5, 2018 /PRNewswire/ — Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today that Dr. Sandy Macrae, CEO of Sangamo, is scheduled to participate in the following healthcare investor conferences in March.

Cowen 38th Annual Health Care Conference,…